Clari Vest Asset Management LLC X4 Pharmaceuticals, Inc Transaction History

Clari Vest Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$6.63 - $10.28 $297,687 - $461,572	-44,900 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$5.41 - $7.4 $4,328 - $5,920	-800 Reduced 1.75%	44,900 $289,000
Q3 2020 Nov 09, 2020	BUY	$6.09 - $9.15 $37,758 - $56,730	6,200 Added 15.7%	45,700 $309,000
Q2 2020 Aug 12, 2020	SELL	$7.98 - $10.44 $19,152 - $25,056	-2,400 Reduced 5.73%	39,500 $368,000
Q1 2020 May 04, 2020	SELL	$6.03 - $11.01 $15,678 - $28,626	-2,600 Reduced 5.84%	41,900 $419,000
Q4 2019 Feb 12, 2020	BUY	$9.93 - $14.33 $441,885 - $637,685	44,500 New	44,500 $476,000

99.6M

421K

80.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $13M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.